STOLFI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 20.517
AS - Asia 2.920
EU - Europa 2.335
SA - Sud America 417
AF - Africa 46
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.246
Nazione #
US - Stati Uniti d'America 20.410
SG - Singapore 1.498
CN - Cina 550
IT - Italia 407
RU - Federazione Russa 376
BR - Brasile 350
DE - Germania 311
HK - Hong Kong 269
VN - Vietnam 243
UA - Ucraina 231
IE - Irlanda 227
GB - Regno Unito 164
SE - Svezia 147
FR - Francia 144
FI - Finlandia 133
JP - Giappone 85
KR - Corea 61
CA - Canada 55
PL - Polonia 52
IN - India 48
BD - Bangladesh 33
MX - Messico 32
NL - Olanda 26
AT - Austria 25
ID - Indonesia 25
AR - Argentina 23
IQ - Iraq 21
ZA - Sudafrica 19
BE - Belgio 18
ES - Italia 18
TR - Turchia 16
CO - Colombia 11
LT - Lituania 11
EC - Ecuador 10
CL - Cile 9
PH - Filippine 9
AU - Australia 8
SA - Arabia Saudita 8
RO - Romania 7
TN - Tunisia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
PY - Paraguay 6
GR - Grecia 5
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
DO - Repubblica Dominicana 4
PK - Pakistan 4
VE - Venezuela 4
AL - Albania 3
CR - Costa Rica 3
DM - Dominica 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
LB - Libano 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
MT - Malta 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
BG - Bulgaria 1
BT - Bhutan 1
GI - Gibilterra 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TL - Timor Orientale 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 26.246
Città #
Woodbridge 5.208
Wilmington 4.610
Houston 4.454
Singapore 918
Fairfield 808
Ashburn 573
Ann Arbor 464
Chandler 431
San Jose 383
Seattle 319
Cambridge 279
Hong Kong 261
Beijing 221
Jacksonville 208
Dublin 205
Medford 164
Rome 154
Council Bluffs 144
Santa Clara 144
New York 131
Dearborn 128
The Dalles 127
Los Angeles 94
Lawrence 72
Hanoi 71
Tokyo 71
Helsinki 68
Buffalo 57
Ho Chi Minh City 57
Moscow 53
Lauterbourg 52
San Diego 45
Chicago 42
Dallas 38
London 35
Kraków 34
São Paulo 32
Zhengzhou 32
Munich 31
Menlo Park 28
Mülheim 27
Milan 26
Orem 25
Redondo Beach 24
Boardman 23
Indianapolis 21
Chennai 19
Nuremberg 19
Brussels 18
Jakarta 18
Toronto 17
Warsaw 17
North Bergen 16
Seoul 16
Lappeenranta 15
Montreal 15
Boston 14
Johannesburg 14
Redwood City 14
Atlanta 12
Belo Horizonte 12
Brooklyn 12
Denver 12
Mountain View 12
Phoenix 12
Shanghai 12
Haiphong 11
Manchester 11
Norwalk 11
Palo Alto 11
Rio de Janeiro 11
San Francisco 11
Vienna 11
Colorado Springs 10
Da Nang 10
Salt Lake City 10
Terzigno 10
Draper 9
Frankfurt am Main 9
Nanjing 9
Naples 9
Chengdu 8
Curitiba 8
Kilburn 8
Querétaro 8
San Mateo 8
Amsterdam 7
Baghdad 7
Dhaka 7
Hangzhou 7
Mexico City 7
Saint Petersburg 7
Stockholm 7
Sydney 7
Tashkent 7
Verona 7
Bari 6
Brasília 6
Charlotte 6
Columbus 6
Totale 21.975
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 564
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 556
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 506
Regulation of gut inflammation and Th17 cell response by interleukin-21 499
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 495
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 486
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 480
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 479
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 478
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 476
The dual role of Smad7 in the control of cancer growth and metastasis 474
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 472
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 469
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery 466
Colorectal cancer chemoprevention by mesalazine and its derivatives 462
Autocrine regulation of IL-21 production in human T lymphocytes 461
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 461
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 459
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 459
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 458
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 457
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 450
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 450
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 447
Collagen matrix injection combined with flap repair for complex anal fistula 445
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 441
The dual role of inflammation in colon carcinogenesis 440
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 435
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 434
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 432
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 431
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 431
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 430
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 415
Role of TH17 cytokines in the control of colorectal cancer 414
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 410
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 406
Molecular basis of the potential of mesalazine to prevent colorectal cancer 401
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer 401
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 391
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 382
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 373
Smad7 positively regulates keratinocyte proliferation in psoriasis 373
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 372
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 369
Interleukin-21 in cancer immunotherapy: Friend or foe? 346
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 338
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 314
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 260
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 247
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 228
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 224
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 222
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 203
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 185
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 183
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 179
Molecular targets of mesalazine in colorectal cancer 151
Association between celiac disease and cancer 147
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 138
Follistatin-like protein 1 sustains colon cancer cell growth and survival 137
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 133
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 130
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 130
Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system 129
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 119
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 103
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures 102
Role of interleukin-34 in cancer 100
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 98
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 97
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 96
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 95
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut 79
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis 77
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 76
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 75
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 74
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 72
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 68
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 68
TRAIL-Sensitizing Effects of Flavonoids in Cancer 67
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? 67
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 67
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 66
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 65
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 59
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 58
Impact of food additives on gut homeostasis 57
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut 55
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 53
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 53
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 52
Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA 51
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 48
Editorial for the Special Issue “Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0” 44
null 44
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy” 43
Editorial for the Special Issue “Latest Review Papers in Molecular Oncology 2023” 34
High Smad7 marks inflammation in patients with chronic pouchitis 31
Totale 26.527
Categoria #
all - tutte 67.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 0 0 0 0 0 169 118 59
2021/2022841 41 94 55 19 28 58 57 28 90 73 68 230
2022/20231.077 97 101 26 133 113 211 91 83 106 28 63 25
2023/2024423 50 17 24 13 42 109 21 80 4 4 2 57
2024/20252.366 71 538 305 179 50 204 144 90 255 259 174 97
2025/20263.906 311 164 422 362 422 173 508 548 548 448 0 0
Totale 26.637